Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bausch Health Companies Inc. (BHC)
Price$6.56Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | $5.77B | $3.48B | $2.43B | $1.18B | $820.4M | $757.2M |
| Gross profit | $7.25B | $6.84B | $6.20B | $5.76B | — | — | — | — | $6.22B | $7.10B | $7.92B | $6.03B | $3.92B | $2.58B | $1.74B | $785.6M | $616.1M | $560.0M |
| Gross margin | 70.65% | 71.10% | 70.78% | 70.90% | — | — | — | — | 71.27% | 73.41% | 75.76% | 73.46% | 68.00% | 73.99% | 71.83% | 66.51% | 75.10% | 73.96% |
| Research & development | $629.0M | $616.0M | $604.0M | $529.0M | $465.0M | $452.0M | $471.0M | $413.0M | $361.0M | $421.0M | $334.0M | $246.0M | $156.8M | $79.1M | $65.7M | $68.3M | $47.6M | $69.8M |
| Operating expenses | $8.45B | $8.08B | $7.79B | $7.67B | $7.98B | $7.35B | $8.80B | $10.76B | $8.62B | $10.24B | $8.92B | $6.21B | $6.18B | $3.40B | $2.13B | $1.29B | $639.3M | $633.1M |
| Operating income | $1.81B | $1.55B | $963.0M | $454.0M | $450.0M | $676.0M | −$203.0M | −$2.38B | $102.0M | −$566.0M | $1.53B | $2.00B | −$409.5M | $79.7M | $300.0M | −$110.1M | $181.2M | $124.1M |
| Operating margin | 17.66% | 16.06% | 11.00% | 5.59% | 5.34% | 8.42% | −2.36% | −28.45% | 1.17% | −5.85% | 14.62% | 24.38% | −7.10% | 2.29% | 12.36% | −9.32% | 22.08% | 16.39% |
| EBITDA | $3.02B | $2.81B | $2.23B | $1.85B | $2.00B | $2.50B | $1.87B | $435.0M | $2.96B | $2.30B | $3.99B | $3.62B | $1.61B | $1.07B | $912.6M | $144.4M | $330.4M | — |
| EBITDA margin | 29.43% | 29.23% | 25.43% | 22.75% | 23.74% | 31.16% | 21.76% | 5.19% | 33.93% | 23.78% | 38.23% | 44.05% | 27.84% | 30.63% | 37.59% | 12.23% | 40.27% | — |
| Net income | $157.0M | −$46.0M | −$592.0M | −$225.0M | −$948.0M | −$560.0M | −$1.79B | −$4.14B | $2.40B | −$2.41B | −$288.0M | $880.0M | −$863.6M | −$116.0M | $159.6M | $366.7M | $406.6M | $199.9M |
| Net profit margin | 1.53% | −0.48% | −6.76% | −2.77% | −11.24% | −6.98% | −20.79% | −49.45% | 27.56% | −24.89% | −2.76% | 10.72% | −14.97% | −3.33% | 6.57% | 31.04% | 49.56% | 26.40% |
| Basic EPSper basic share | $0.42 | -$0.13 | -$1.62 | -$0.62 | -$2.64 | -$1.58 | -$5.08 | -$11.81 | $6.86 | -$6.94 | -$0.85 | $2.63 | -$2.70 | -$0.38 | $0.52 | -$1.06 | $1.11 | $1.25 |
| Diluted EPSper diluted share | $0.42 | -$0.13 | -$1.62 | -$0.62 | -$2.64 | -$1.58 | -$5.08 | -$11.81 | $6.83 | -$6.94 | -$0.85 | $2.58 | -$2.70 | -$0.38 | $0.49 | -$1.06 | $1.11 | $1.25 |
Owners
Reported shareholders
≈19.70%of listed shares
Paulson John73.67M shares · May 22, 2026
View holders
| Holder | % owned |
|---|---|
Paulson John | ≈19.70%73.67M shares |
PAULSON & CO. INC. | 19.59%73.26M shares |
GOLDENTREE ASSET MANAGEMENT LP | 9.27%34.67M shares |
ROYAL BANK OF CANADA | 2.90%10.83M shares |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2.14%8M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.00%7.47M shares |
GOLDMAN SACHS GROUP INC | 1.66%6.23M shares |
MFN Partners Management, LP | 1.60%6M shares |
SG Americas Securities, LLC | 1.48%5.54M shares |
ACADIAN ASSET MANAGEMENT LLC | 1.47%5.48M shares |
Kohlberg Kravis Roberts & Co. L.P. | 1.40%5.24M shares |
ING GROEP NV | 1.34%5M shares |
Hudson Bay Capital Management LP | 1.34%5M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.28%4.8M shares |
GENDELL JEFFREY L | 1.08%4.04M shares |
NORGES BANK | 0.92%3.43M shares |
MACQUARIE GROUP LTD | 0.87%3.25M shares |
DIMENSIONAL FUND ADVISORS LP | 0.87%3.24M shares |
D. E. Shaw & Co., Inc. | 0.72%2.69M shares |
APPIO THOMAS | ≈0.62%2.32M shares |
Percentages use 373.9M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026Form 4 · 10b5-1 | Lee Frank D.Director | SellCommon Shares, No Par Value | 24.5K | $5.43 | $132.8K | 49.3K |
| Mar 3, 2026Form 4 · 10b5-1 | Carson SeanaEVP, General Counsel | SellCommon Shares, No Par Value | 4.4K | $5.77 | $25.5K | 616.8K |
| Mar 2, 2026Form 4 · 10b5-1 | Carson SeanaEVP, General Counsel | SellCommon Shares, No Par Value | 6.9K | $5.78 | $39.6K | 776.1K |
| Feb 27, 2026Form 4 · 10b5-1 | Carson SeanaEVP, General Counsel | SellCommon Shares, No Par Value | 8.4K | $5.95 | $49.9K | 809.3K |
| Nov 25, 2025Form 4 | PAULSON & CO. INC.TenPercentOwner | BuyCommon Stock, no par value · indirect | 2.50M | $6.25 | $15.63M | 73.26M |